#	Pagina
attuale pagina	/open-h2020/projects/223427/index.html

Opendata, web and dolomites

BodyDMI SIGNED

Development of deuterium metabolic imaging to map body biochemistry with MRI

Total Cost €

EC-Contrib. €

Partnership

Views

BodyDMI project word cloud

Explore the words cloud of the BodyDMI project. It provides you a very rough idea of what is the project "BodyDMI" about.

mcube metabolism dmi resonance diseases coils biochemistry 300 therapies frequency stage arguably oral dipole valorized linked opens uncompromised fet diabetes innovation ed outperforms earlier spectroscopic optimal setup operation scanner labeled besides cancer 01 patients organ complement administration deuterium lipid techniques compounds mode drug map mri dual efficacy attributed dramatic imaging designs loop obesity metabolic combined proof outperformed dynamically lack global humans scan mhz carbohydrate commercial disturbances coil transparent invasive treatment relies session 2017 hepatic image window clinical detect toxicity operates ultra successful designed chemical hydrogen epidemic feasibility morphological completion 45 magnetic tesla array idea dynamic body 3d sensitivity 2016 lagged

Project "BodyDMI" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITAIR MEDISCH CENTRUM UTRECHT Organization address address: HEIDELBERGLAAN 100 city: UTRECHT postcode: 3584 CX website: www.umcutrecht.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Total cost	100˙000 €
EC max contribution	100˙000 € (100%)
Programme	1. H2020-EU.1.2.1. (FET Open)
Code Call	H2020-FETOPEN-2018-2019-2020-03
Funding Scheme	CSA
Starting year	2019
Duration (year-month-day)	from 2019-06-01 to 2020-11-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITAIR MEDISCH CENTRUM UTRECHT UNIVERSITAIR MEDISCH CENTRUM UTRECHT Organization address address: HEIDELBERGLAAN 100 city: UTRECHT postcode: 3584 CX website: www.umcutrecht.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (UTRECHT)	coordinator	81˙250.00
2	WAVETRONICA BV WAVETRONICA BV Organization address address: PADUALAAN 8 ROOM Z109 city: UTRECHT postcode: 3584 CH website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (UTRECHT)	participant	18˙750.00
3	MR COILS BV MR COILS BV Organization address address: SHIMMINCK 18 city: ZALTBOMMEL postcode: 5301 KR website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ZALTBOMMEL)	participant	0.00

Map

Project objective

The global obesity epidemic has resulted in a dramatic rise in metabolic diseases and the development of effective therapies has greatly lagged behind. This could arguably be attributed to a lack of non-invasive (imaging) techniques to characterize disturbances in metabolic pathways. We will investigate the use of dynamic deuterium metabolic imaging (DMI) to dynamically map body biochemistry in humans in 3D imaging mode. DMI relies on deuterium magnetic resonance spectroscopic imaging combined with oral administration of deuterium-labeled compounds.

The innovation idea is linked to the MCUBE project of FET-OPEN-01-2016-2017. Here a dual-dipole coil was designed for hydrogen MRI at 7 tesla (300 MHz), which outperformed the state-of-the-art setup of the loop-dipole coil for MRI. The new design is transparent to loop designs, meaning that the setup can be combined with loop coils, which are known to be the optimal setup for low frequency operation. So for DMI, which operates at 45.7 MHz (low frequency) at 7 tesla, an MRI coil array can be designed that not only outperforms MRI, but also enables DMI at uncompromised sensitivity within the same scan session, which will complement the utilization of the MCUBE project.

The objectives of the project are: (1) Build and test a body DMI setup for a clinical ultra-high field 7 tesla MRI scanner; (2) demonstrate proof of concept to measure hepatic carbohydrate and lipid metabolism with DMI; and (3) apply DMI in a clinical feasibility study in type 2 diabetes patients. Upon successful completion of the project, DMI will be valorized by the commercial partners and embedded in clinical practice, which opens up a new window for drug studies to directly image their chemical efficacy. Besides its application in metabolic diseases, DMI has potential to detect organ failure, drug toxicity and effects of cancer treatment in a much earlier stage than morphological imaging.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BODYDMI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BODYDMI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.